We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Topical Immunotherapy Lowers Risk of Skin Cancer

News   Mar 22, 2019 | Original story from Washington University School of Medicine in St. Louis

 
Topical Immunotherapy Lowers Risk of Skin Cancer

Washington University dermatologist Lynn Cornelius, MD, (left) conducts a skin exam with patient Robert Manchester. Manchester was a participant in a clinical trial testing the effectiveness of a topical immunotherapy against precancerous skin lesions called actinic keratoses, often found on sun-damaged skin. A three-year follow-up analysis suggests the therapy also reduces the risk that the precancerous lesions will progress to skin cancer. Credit: Washington University

 
 
 

RELATED ARTICLES

Vitamin D Metabolites Influence T Cell Priming

News

Fresh insights on the effect of vitamin D on the immune system add to the greater picture of how vitamin D might influence susceptibility to inflammatory diseases.

READ MORE

HIV Suppressed for up to Four Months by Novel Antibody

News

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months.

READ MORE

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE